Walleye Trading LLC Esperion Therapeutics, Inc. Put Options Transaction History

Walleye Trading LLC

$41.2 Billion
Q2 2024

Put Options

24 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q1 2024 May 15, 2024	SELL	$2.02 - $3.02 $24,038 - $35,938	-11,900 Reduced 9.93%	107,900 $289,000
Q4 2023 Feb 14, 2024	BUY	$0.73 - $3.08 $73,876 - $311,696	101,200 Added 544.09%	119,800 $358,000
Q3 2023 Nov 14, 2023	SELL	$0.96 - $1.79 $19,200 - $35,800	-20,000 Reduced 51.81%	18,600 $18,000
Q2 2023 Aug 14, 2023	BUY	$1.2 - $1.76 $46,200 - $67,760	38,500 Added 38500.0%	38,600 $53,000
Q1 2023 May 15, 2023	SELL	$1.46 - $7.3 $89,644 - $448,220	-61,400 Reduced 99.84%	100 $0
Q4 2022 Feb 14, 2023	SELL	$5.09 - $8.5 $208,181 - $347,650	-40,900 Reduced 39.94%	61,500 $383,000
Q3 2022 Nov 14, 2022	BUY	$5.45 - $8.13 $277,950 - $414,630	51,000 Added 99.22%	102,400 $686,000
Q2 2022 Aug 08, 2022	BUY	$4.77 - $6.67 $240,407 - $336,168	50,400 Added 5040.0%	51,400 $327,000
Q1 2022 May 16, 2022	SELL	$3.34 - $5.56 $521,040 - $867,359	-156,000 Reduced 99.36%	1,000 $5,000
Q4 2021 Feb 14, 2022	SELL	$4.81 - $11.92 $214,525 - $531,632	-44,600 Reduced 22.12%	157,000 $785,000
Q3 2021 Nov 15, 2021	BUY	$11.34 - $21.37 $2.15 Million - $4.05 Million	189,500 Added 1566.12%	201,600 $2.43 Million
Q2 2021 Aug 16, 2021	BUY	$19.4 - $28.71 $3,879 - $5,742	200 Added 1.68%	12,100 $256,000
Q1 2021 May 17, 2021	BUY	$25.12 - $36.89 $188,400 - $276,675	7,500 Added 170.45%	11,900 $334,000
Q4 2020 Feb 16, 2021	BUY	$24.2 - $35.76 $106,480 - $157,344	4,400 New	4,400 $114,000
Q3 2020 Nov 16, 2020	SELL	$31.18 - $52.71 $155,900 - $263,550	-5,000 Closed	0 $0
Q2 2020 Aug 14, 2020	BUY	$30.04 - $51.31 $72,096 - $123,144	2,400 Added 92.31%	5,000 $257,000
Q1 2020 May 15, 2020	SELL	$27.44 - $73.84 $101,528 - $273,208	-3,700 Reduced 58.73%	2,600 $82,000
Q4 2019 Feb 14, 2020	SELL	$35.4 - $59.82 $92,040 - $155,532	-2,600 Reduced 29.21%	6,300 $376,000
Q3 2019 Nov 14, 2019	BUY	$34.47 - $47.53 $165,456 - $228,144	4,800 Added 117.07%	8,900 $326,000
Q2 2019 Aug 14, 2019	SELL	$40.1 - $52.33 $401,000 - $523,300	-10,000 Reduced 70.92%	4,100 $191,000
Q1 2019 May 15, 2019	BUY	$40.11 - $53.57 $12,033 - $16,071	300 Added 2.17%	14,100 $566,000
Q4 2018 Feb 14, 2019	BUY	$36.99 - $59.11 $510,462 - $815,718	13,800 New	13,800 $635,000
Q3 2018 Nov 14, 2018	SELL	$40.74 - $51.41 $8,148 - $10,282	-200 Closed	0 $0
Q2 2018 Aug 14, 2018	BUY	$36.2 - $76.4 $7,240 - $15,280	200 New	200 $8,000

Others Institutions Holding ESPR

# of Institutions

197

Shares Held

136M

Call Options Held

2.72M

Put Options Held

1.3M

Wasatch Advisors Inc Salt Lake City, UT

16.9M
Shares

$35.9 Million
0.2% of portfolio
Black Rock Inc. New York, NY

14M
Shares

$29.8 Million
0.0% of portfolio
Vanguard Group Inc Valley Forge, PA

10.8M
Shares

$23 Million
0.0% of portfolio
Bellevue Group Ag Kuesnacht, V8

9.94M
Shares

$21.2 Million
0.37% of portfolio
Israel Englander Millennium Management LLC | New York, Ny

6.51M
Shares

$13.9 Million
0.01% of portfolio

View Full List

About Esperion Therapeutics, Inc.

Ticker ESPR
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 66,551,600
Market Cap $142M
Description
Esperion Therapeutics, Inc., a pharmaceutical company, develops and commercializes medicines for the treatment of patients with elevated low density lipoprotein cholesterol. Its lead product candidates are NEXLETOL (bempedoic acid) and NEXLIZET (bempedoic acid and ezetimibe) tablets for the treatment of patients with atherosclerotic cardiovascul...

More about ESPR

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Walleye Trading LLC, based on Form 13F filings with the SEC.

News

Stay updated on Walleye Trading LLC with notifications on news.

Account